Mark Simon - Net Worth and Insider Trading
Mark Simon Net Worth
The estimated net worth of Mark Simon is at least $2 Million dollars as of 2024-05-16. Mark Simon is the Director of Cabaletta Bio Inc and owns about 143,144 shares of Cabaletta Bio Inc (CABA) stock worth over $2 Million. Details can be seen in Mark Simon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Simon has not made any transactions after 2022-10-18 and currently still holds the listed stock(s).
Transaction Summary of Mark Simon
Mark Simon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Simon owns 2 companies in total, including Cabaletta Bio Inc (CABA) , and Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of Mark Simon’s form 4 insider trades.
Insider Ownership Summary of Mark Simon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CABA | Cabaletta Bio Inc | 2022-10-18 | director |
| FOLD | Amicus Therapeutics Inc | 2007-05-30 | Sr. VP & Business Development |
Mark Simon Latest Holdings Summary
Mark Simon currently owns a total of 1 stock. Mark Simon owns 143,144 shares of Cabaletta Bio Inc (CABA) as of October 18, 2022, with a value of $2 Million.
Latest Holdings of Mark Simon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CABA | Cabaletta Bio Inc | 2022-10-18 | 143,144 | 12.55 | 1,796,457 |
Holding Weightings of Mark Simon
Mark Simon Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Simon has made a total of 1 transactions in Cabaletta Bio Inc (CABA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cabaletta Bio Inc is the acquisition of 125,000 shares on October 18, 2022, which cost Mark Simon around $122,500.
Insider Trading History of Mark Simon
- 1
Mark Simon Trading Performance
GuruFocus tracks the stock performance after each of Mark Simon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Simon is 1018.62%. GuruFocus also compares Mark Simon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Simon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Simon's insider trading performs compared to the benchmark.
Performance of Mark Simon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 292.37 | | | | | |
| Relative Return to S&P 500(%) | 285.77 | | | | | |
Mark Simon Ownership Network
Mark Simon Owned Company Details
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Mark Simon is the director of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Mark Simon made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
Mark Simon Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Simon. You might contact Mark Simon via mailing address: C/o Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
